# OnCo record aya-cancers (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/aya-cancers/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "aya-cancers" ;
  schema:name "Adolescent and young adult cancers (ages 15 to 39)"@en ;
  schema:alternateName "AYA cancers"@en, "Teenage and young adult cancer"@en, "TYA cancer"@en, "Young adult cancer"@en ;
  schema:description "People aged 15 to 39 get a different mix of cancers from children or older adults: leukaemia, lymphoma, testicular and thyroid cancer, melanoma, sarcoma and brain tumours in the younger years, then breast, cervical and bowel cancer towards 40. For decades their survival improved more slowly than anyone else's: they fell between children's and adults' hospitals and joined few trials."@en ;
  schema:url <https://onco.cc/cancers/aya-cancers/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Adolescent_and_young_adult_oncology> ;
  schema:citation <https://en.wikipedia.org/wiki/Adolescent_and_young_adult_oncology>, <https://www.cancer.gov/types/aya> ;
  onco:tag "umbrella", "subtype-page", "aya" ;
  onco:related <https://onco.cc/cancers/childhood-cancers/> ;
  onco:cancers <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/all-ph-like/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/testicular/>, <https://onco.cc/cancers/paediatric-germ-cell-tumours/>, <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/ewing-sarcoma/>, <https://onco.cc/cancers/osteosarcoma/>, <https://onco.cc/cancers/brain-tumours/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/early-onset-colorectal/> ;
  onco:technologies <https://onco.cc/technologies/fertility-preservation/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/psycho-oncology/> ;
  onco:institutions <https://onco.cc/institutions/teenage-cancer-trust/>, <https://onco.cc/institutions/childrens-oncology-group/> ;
  onco:terms <https://onco.cc/terms/aya-oncology/>, <https://onco.cc/terms/late-effects/>, <https://onco.cc/terms/financial-toxicity/>, <https://onco.cc/terms/cancer-in-pregnancy/> ;
  onco:trials <https://onco.cc/trials/e1910/>, <https://onco.cc/trials/ccss/> ;
  onco:pipeline <https://onco.cc/drugs/blinatumomab/>, <https://onco.cc/trials/e1910/>, <https://onco.cc/ideas/idea-acc-aya-survivorship-passport/>, <https://onco.cc/ideas/idea-acc-default-fertility-preservation-referral/>, <https://onco.cc/ideas/idea-acc-national-late-effects-registry/>, <https://onco.cc/technologies/fertility-preservation/>, <https://onco.cc/technologies/ngs-mrd-clonoseq/> ;
  onco:standardOfCare <https://onco.cc/drugs/asparaginase/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/dexamethasone/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/blinatumomab/>, <https://onco.cc/trials/e1910/>, <https://onco.cc/technologies/ngs-mrd-clonoseq/>, <https://onco.cc/key-papers/paper-e1910-blinatumomab-mrd-negative-all-nejm-2024/>, <https://onco.cc/technologies/fertility-preservation/>, <https://onco.cc/technologies/psycho-oncology/>, <https://onco.cc/terms/financial-toxicity/>, <https://onco.cc/institutions/teenage-cancer-trust/>, <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/terms/late-effects/>, <https://onco.cc/technologies/cardio-oncology/>, <https://onco.cc/ideas/idea-acc-aya-survivorship-passport/>, <https://onco.cc/trials/ccss/>, <https://onco.cc/technologies/germline-testing/> .